In this regard, elevated levels of metabolic enzymes, such as lactate dehydrogenase A (LDHA) and pyruvate kinase M (PKM), have been suggested to be highly reproducible biomarkers in the CSF of individuals with AD (Higginbotham et al., 2020; Sathe et al., 2019). This evidence concerns the gene PKM and Alzheimer disease.